Home  |  Contact

UniProtKB/Swiss-Prot Q9UPM9: Variant p.Arg61Trp

B9 domain-containing protein 1
Gene: B9D1
Variant information

Variant position:  61
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Arginine (R) to Tryptophan (W) at position 61 (R61W, p.Arg61Trp).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and basic (R) to large size and aromatic (W)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  61
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  204
The length of the canonical sequence.

Location on the sequence:   APTAGLEEGISQITSKSQDV  R QALVWNFPIDVTFKSTNPYG
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         APTAGLEEGISQITSKSQD-VRQALVWNFPIDVTFKSTNPYG

Mouse                         APTAGLEEGISQIASKSQD-VRQALVWNFPIDVTFKSTNPY

Rat                           APTAGLEEGISQIASKSQD-VRQALVWNFPIDVTFKSTNPY

Xenopus laevis                APTSGIEEGISQITSKSQG-GKQTLVWNFPVEITFKSTNPY

Xenopus tropicalis            APTSGVEEGISQITSKSQG-GKQALVWNFPIEITFKSTNPF

Zebrafish                     APTSGLEEGISQITSKGR--LSQSLVWNFPLDITFKSTNPF

Drosophila                    QLSSGPQHGLTQLATNRRGHFNEPIVFNMPIEVTYKSTSPY

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 204 B9 domain-containing protein 1
Domain 9 – 127 C2 B9-type


Literature citations

B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis.
Hopp K.; Heyer C.M.; Hommerding C.J.; Henke S.A.; Sundsbak J.L.; Patel S.; Patel P.; Consugar M.B.; Czarnecki P.G.; Gliem T.J.; Torres V.E.; Rossetti S.; Harris P.C.;
Hum. Mol. Genet. 20:2524-2534(2011)
Cited for: INVOLVEMENT IN MKS9; VARIANT TRP-61;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.